CRH receptors in myometrium
CRH receptors in myometrium
批准号:
nhmrc : 455557
负责人:
A/Pr Dimitris Grammatopoulos
金额:
$30.66万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Premature birth is a major cause of neonatal death and intellectual and other handicaps among the survivors. While neonatal intensive care has improved the survival of premature babies, there has been no reduction in the number of premature babies born, in fact the numbers are increasing. Our inability to reduce premature birth is partly related to our lack of knowledge of the physiological processes that lead to normal labour. As a result many of our drugs for women in premature labour are not very effective. Our work has shown that a hormone called corticotrophin releasing hormone (CRH) made in the placenta plays a critical role in determining the length of a pregnancy. We have measured the levels of this hormone in the blood of pregnant women and shown that it increases more rapidly than normal in women who deliver prematurely and more slowly than normal in women who deliver late. It acts as a kind of clock to determine the length of pregnancy. What is not known is how this hormone acts to bring on labour. What is particularly puzzling is that some of the actions of the CRH seem likely to cause the uterus to relax rather than to contract. We wish to test the idea that the rapidly rising levels of this hormone in late pregnancy cause changes in the uterus that stop the pathways to relaxation and lead to contraction. To perform these studies we will use small pieces of uterus donated with informed consent from women undergoing caesarean section. The results of these studies may allow us to design better ways of preventing premature birth and prevent many cases of cerebral palsy and intellectual handicap.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
BMP9/BMP type I receptors 通过激活 PPARα保护心肌梗死的机制研究
-
批准号:LQ22H020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈灵丽
-
依托单位:
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
-
批准号:81171510
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:李若瑜
-
依托单位:
Toll样受体在糖尿病视网膜病变中作用及其可能信号传导机制
-
批准号:81141008
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2011
-
负责人:王康
-
依托单位:
TRPCs,STIMs及Orais在钙敏感受体介导钙内流及一氧化氮生成中作用和机制研究
-
批准号:31160239
-
项目类别:地区科学基金项目
-
资助金额:53.47万元
-
批准年份:2011
-
负责人:何芳
-
依托单位:
TLRs和Th1/Th2漂移在肺脏对大气污染炎症反应中的地位和作用
-
批准号:81070006
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:王广发
-
依托单位:
警报素(alarmin)HMGN1作为DNA疫苗佐剂的应用基础研究
-
批准号:30901376
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2009
-
负责人:魏枫
-
依托单位:
Toll样受体信号途径中TRAF6的调控机制
-
批准号:30871288
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:陈丹英
-
依托单位:
Oleamide 对神经细胞钠离子通道(VSSCs)及GABAa Receptors
-
批准号:30240004
-
项目类别:专项基金项目
-
资助金额:7.0万元
-
批准年份:2002
-
负责人:郑健
-
依托单位: